Biswas Priyanka Paul, Dey S, Adhikari L, Sen Aninda
Department of Microbiology, Katihar Medical College, Katihar, Bihar, India.
Department of Microbiology, Sikkim Manipal University, Gangtok, Sikkim, India.
Indian J Pathol Microbiol. 2016 Apr-Jun;59(2):188-93. doi: 10.4103/0377-4929.182015.
The aim of this study was to find out the clinical correlation between the presence of vancomycin-resistant genes (van A and van B) and their expression as detected by phenotypic tests in colonized patients and in clinical isolates.
Enterococci were isolated from various clinical samples and also from fecal specimens of colonized patients at the time of admission, after 48 h and after 5 days of admission. Identification to species level was done using standard methods. Vancomycin susceptibility in Enterococci was detected by disc diffusion test. Minimum inhibitory concentration was determined by agar dilution method. Multiplex polymerase chain reaction (PCR) was used to detect the presence of van genes.
Out of all the clinical and fecal samples processed, 12.0% isolates were either vancomycin resistant or vancomycin intermediate. Further, these isolates carried van A or van B genes as confirmed by PCR methods. Expression of van A gene was found to be more in Enterococcus faecalis (28.3%) as compared to Enterococcus faecium (25.0%) in both clinical and fecal isolates. 16.6% strains of E. faecium and 15.0% strains each of E. faecalis and Enterococcus gallinarum were found to carry van B genes. The overall prevalence of vancomycin resistant Enterococci (VRE) in colonized patients was about 9.6%. Prior administration of antibiotics had significant effect (P = 0.001) on VRE carriage. Urinary tract infection was the most common infection caused by vancomycin susceptible Enterococci (VSE), 105/214 (49.0%) and VRE, 13/36 (36.1%). There was no significant difference (P = 0.112) in the distribution of VRE and VSE in different infection types. Both clinical and fecal VRE showed maximum resistance to penicillin, ampicillin, and piperacillin. Resistance to linezolid was 2.8% in clinically isolated VRE.
VRE in our study were found to be resistant to a number of commonly used antibiotics. The frequency of isolation of vancomycin resistant E. faecalis (VRE.fs), which is highly virulent, and the number of strains harboring van A gene in our hospital setup is high and needs to be addressed.
本研究的目的是找出在定植患者和临床分离株中,耐万古霉素基因(van A和van B)的存在与其通过表型试验检测到的表达之间的临床相关性。
从各种临床样本以及定植患者入院时、入院48小时后和入院5天后的粪便标本中分离肠球菌。使用标准方法进行菌种鉴定。通过纸片扩散试验检测肠球菌对万古霉素的敏感性。采用琼脂稀释法测定最低抑菌浓度。运用多重聚合酶链反应(PCR)检测van基因的存在。
在所有处理的临床和粪便样本中,12.0%的分离株对万古霉素耐药或中介。此外,经PCR方法证实,这些分离株携带van A或van B基因。在临床和粪便分离株中,粪肠球菌(28.3%)中van A基因的表达高于屎肠球菌(25.0%)。发现16.6%的屎肠球菌菌株以及粪肠球菌和鹑鸡肠球菌各15.0%的菌株携带van B基因。定植患者中耐万古霉素肠球菌(VRE)的总体患病率约为9.6%。先前使用抗生素对VRE携带情况有显著影响(P = 0.001)。尿路感染是由万古霉素敏感肠球菌(VSE)引起的最常见感染,105/214(49.0%),以及由VRE引起的感染,13/36(36.1%)。不同感染类型中VRE和VSE的分布无显著差异(P = 0.112)。临床和粪便VRE对青霉素、氨苄西林和哌拉西林的耐药性最强。临床分离的VRE对利奈唑胺的耐药率为2.8%。
本研究中的VRE对多种常用抗生素耐药。我院高毒力的耐万古霉素粪肠球菌(VRE.fs)的分离频率以及携带van A基因的菌株数量较高,需要加以解决。